(Press-News.org) Contact information: Dana Korsen
aaps@ecius.net
301-744-9636
American Association of Pharmaceutical Scientists
Breathalyzer technology detects acetone levels to monitor blood glucose in diabetics
Groundbreaking research to be featured at 2013 AAPS Annual Meeting and Exposition
Arlington, Va. — A novel hand-held, noninvasive monitoring device that uses multilayer nanotechnology to detect acetone has been shown to correlate with blood-glucose levels in the breath of diabetics. This research is being presented at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10-14.
Diabetes, which affects an estimated 347 million people worldwide according to the World Health Organization, is an autoimmune disease that prevents the natural cellular uptake of sugar from the blood and often requires continuous blood-glucose monitoring. Current technology, such as the blood glucose meter, is invasive and causes discomfort to patients, often resulting in low compliance. This in turn can ultimately lead to poor health outcomes.
Ronny Priefer, Ph.D., of Western New England University, created the multilayer technology using nanometer-thick films consisting of two polymers that react with acetone. This crosslinks the polymers and alters the physicochemical nature of the film, which provides a quantification of the acetone and thus the blood-glucose levels.
"Breathalyzers are a growing field of study because of their potential to have a significant positive impact on patients' quality of life and compliance with diabetes monitoring. What makes our technology different is that it only accounts for acetone and doesn't react with other components in the breath," said Priefer. "The breathalyzer we currently have is about the size of a book, but we're working with an engineer, Dr. Michael Rust at Western New England University, to make it smaller, more similar to the size of a breathalyzer typically used to detect blood alcohol content levels."
Other common shortfalls with current attempted breathalyzer technology are inconstant results due to the natural humidity of one's breath, high temperature requirements, and lack of selectivity.
Priefer has two Western New England University clinics lined up to perform controlled testing with patients in late 2014–early 2015. This testing would compare readings from the breathalyzer, finger pricking, and actual glucose levels from drawn blood. Priefer is planning for patients to test the breathalyzers in an uncontrolled setting in about two years, keeping a diary of their readings and reporting back.
###
The 2013 AAPS Annual Meeting and Exposition aims to improve global health through advances in pharmaceutical sciences, and there will be 480 exhibits and an estimated 7,500 attendees. The meeting features nearly 105 programming sessions, including more than 50 symposia and roundtables and more than 2,200 posters. Download the AAPS smartphone application for additional information.
Editor's Note: All press must provide press credentials to attend this meeting and register on-site in the press room #213. To schedule an interview with Dr. Priefer or for any other press inquiry, please contact Hillarie Turner or Dana Korsen at aaps@ecius.net or 202-296-2002. For the most up-to-date program information, please click here.
Images are available upon request.
About AAPS:
The American Association of Pharmaceutical Scientists is a professional, scientific association of approximately 11,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to serve the public and enhance their contributions to health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development. For more information, please visit http://www.aaps.org. Follow us on Twitter @AAPSComms; official Twitter hashtag for the meeting is: #AAPS2013.
Breathalyzer technology detects acetone levels to monitor blood glucose in diabetics
Groundbreaking research to be featured at 2013 AAPS Annual Meeting and Exposition
2013-11-13
ELSE PRESS RELEASES FROM THIS DATE:
New compound inhibits cognitive impairment in animal models of Alzheimer's disease
2013-11-13
New compound inhibits cognitive impairment in animal models of Alzheimer's disease
Promising research to be featured at 2013 AAPS Annual Meeting and Exposition
Arlington, Va. — The novel compound IRL-1620 may be useful in treating Alzheimer's ...
Study finds context is key in helping us to recognize a face
2013-11-13
Study finds context is key in helping us to recognize a face
Why does it take longer to recognise a familiar face when seen in an unfamiliar setting, like seeing a work colleague when on holiday? A new study published today in Nature Communications has found that part ...
Young stars paint spectacular stellar landscape
2013-11-13
Young stars paint spectacular stellar landscape
Most stars do not form alone, but with many siblings that are created at about the same time from a single cloud of gas and dust. NGC 3572, in the southern constellation of Carina (The Keel), is one of these clusters. It contains many hot ...
Human stem cells used to elucidate mechanisms of beta-cell failure in diabetes
2013-11-13
Human stem cells used to elucidate mechanisms of beta-cell failure in diabetes
Mechanisms that impair insulin production in diabetes identified using a human stem cell model of Wolfram syndrome, a rare form of diabetes
NEW YORK, NY (November 13, 2013) – Scientists ...
Don't hold the anchovies: Study shows Peruvian fish worth more as food than as feed
2013-11-13
Don't hold the anchovies: Study shows Peruvian fish worth more as food than as feed
The true potential of Peruvian anchovy lies not in fishmeal but as food for people and as part of the ocean food web, according to Canadian and Peruvian researchers.
The ...
Social networks make us smarter
2013-11-13
Social networks make us smarter
The secret to why some cultures thrive and others disappear may lie in our social networks and our ability to imitate, rather than our individual smarts, according to a new University of British Columbia study.
The study, ...
Designing principles and optimization approaches of a bio-inspired self-organized network
2013-11-13
Designing principles and optimization approaches of a bio-inspired self-organized network
By observing the collective behaviors of social species, artificial self-organized systems are expected to exhibit some intelligent features that may have made social species so ...
Healing powers
2013-11-13
Healing powers
Carl-Philipp Heisenberg group detects mechanism in cell division relevant for closing wounds
This news release is available in German. Spreading of the epithelial cell layer is fundamental for epithelial closure ...
Natural disasters of the past can help solve future problems
2013-11-13
Natural disasters of the past can help solve future problems
Were you one of the many people who got stuck in an airport when the Icelandic volcano Eyjafjallajökull erupted in 2010? It wasn't a major eruption, and it happened a long way from the heart of Europe. But it ...
New generation of micro sensors for monitoring ocean acidification
2013-11-13
New generation of micro sensors for monitoring ocean acidification
The first step in developing a cost-effective micro sensor for long-term monitoring of ocean acidification has been achieved by a team of scientists and engineers.
The new ...
LAST 30 PRESS RELEASES:
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
When getting a job makes you go hungry
Good vibrations could revolutionize assisted reproductive technology
[Press-News.org] Breathalyzer technology detects acetone levels to monitor blood glucose in diabeticsGroundbreaking research to be featured at 2013 AAPS Annual Meeting and Exposition